Endiatx prepares PillBot for FDA approval and begins limited clinical trials with the latest generation of the device.

Rodney Brooks, Sergey Levine, Claire Delaunay, a state-of-the-industry panel, and a live demo of a swallowable robotic pill will headline leading commercial robotics event.

On this episode we talk to Oana Jinga, co-founder of Dexory, and Garrett Place, business development at ifm.

Endiatx plans to publish data from in-human trials, saying they are “progressing well, and physicians appreciate the technology.”